Medite Cancer Diagnostics Inc (MDIT)

[IslandTrader]

Vette - in that sense it dilutes or devalues the stock; however don't forget all we really had was R&D, patents and a publicly traded company/shell already in place to launch from immediately. Medite has real assets and 9.5 Million in revenue a year just from what they have been doing themselves. So we have pooled all of that together and split it up. I agree, whatever the case I feel sailing on this ship is going to take us to wonderful destinations.